Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) has received an average recommendation of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $5,400.00.
Separately, JPMorgan Chase & Co. lowered Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research note on Thursday.
Check Out Our Latest Research Report on RBGLY
Reckitt Benckiser Group Trading Down 1.1 %
Shares of OTCMKTS RBGLY traded down $0.13 during midday trading on Thursday, hitting $11.53. The company's stock had a trading volume of 435,255 shares, compared to its average volume of 927,363. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03. The business's 50 day moving average is $11.09 and its two-hundred day moving average is $11.59.
Reckitt Benckiser Group Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Monday, September 23rd. Investors of record on Monday, August 5th will be issued a $0.1915 dividend. The ex-dividend date of this dividend is Monday, August 5th.
Reckitt Benckiser Group Company Profile
(
Get Free ReportReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
